PRS31 Economic Evaluation of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) From the Public Payer Perspective in Brazil
Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.1418
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV